AI is Boosting Pharma Profits. Here’s Our 8.8% Dividend Play.
This high-yield fund is trading for 11.4% below its “true” value.
Read MorePosted by Brett Owens, Contrarian Outlook | Mar 4, 2026
This high-yield fund is trading for 11.4% below its “true” value.
Read MorePosted by Brett Owens, Contrarian Outlook | Feb 19, 2026
We have a particularly timely buy window right now.
Read MorePosted by Brett Owens, Contrarian Outlook | Feb 13, 2026
Dividend payers like this one are the cornerstone of my “Monthly Dividend Portfolio.”
Read MorePosted by Brett Owens, Contrarian Outlook | Feb 2, 2026
Washington just put a target on bank profits— so we’re rotating into an 8.1% pipeline tollbooth that gets paid no matter what.
Read MorePosted by Brett Owens, Contrarian Outlook | Jan 22, 2026
We now have a chance to buy a stout dividend grower at a bargain.
Read More